A Pharmaceutical composition comprising 5-chloro-2 - (5R) - 5 - methyl - 4 - methyl - 5 - [2 - (2H - 1,2,3 triazol - il - 2) benzoyl] - 1.4 - diazepam - il - 1} - 1.3 - benzoxazole； or a pharmaceutically acceptable Salt thereof and its use in the preparation of medicines
A Pharmaceutical composition which comprises a pharmaceutically acceptable Carrier and 5-chloro-2 - (5R) - 5 - methyl - 4 - methyl - 5 - [2 - (2H - 1,2,3 triazol - il - 2) benzoyl] - 1.4 - diazepam - il - 1} - 1.3 - benzoxazole； or pharmaceutically acceptable Salt thereof. It also describes their use in the preparation of drugs for the treatment of insomnia.Una composición farmacéutica caracterizada porque comprende un portador farmacéuticamente aceptable y 5-cloro-2-{(5R)-5-metil-4-[5-metil-2-(2H-1,2,3-triazol-2-il)benzoil]-1,4-diazepan-1-il}-1,3-benzoxazol； o una sal farmacéuticamente aceptable del mismo. También se describe su uso en la preparación de medicamentos para el tratamiento del insomnio.
